Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 ,inter alia, to consider and approve Notice is hereby given ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has informed BSE that its Board of Directors will meet on Wednesday, 30th July 2025. The main agenda is to consider and approve the Unaudited Financial Results and Statements, both Standalone and Consolidated, for the quarter ended 30th June 2025 (Q1 FY26). This is a routine regulatory disclosure under SEBI Listing Regulations. No financial numbers, projections, or specific business decisions have been mentioned in this notice.
This is a standard advance notice and does not impact shareholders immediately. Investors should watch for the actual Q1 results announcement after 30th July to assess the company's quarterly performance, revenue trends, and profitability.